Amendment #1 to the Letter of IntentAccelr8 Technology Corp • April 18th, 2011 • Laboratory analytical instruments
Company FiledApril 18th, 2011 IndustryIncorporating the terms and conditions of the Letter of Intent Agreement, effective as of June 14, 2010 (hereinafter collectively referred to as the "Agreement"), made by and between Novartis Vaccines and Diagnostics Inc. ("Novartis V&D") and Accelr8 Technology Corporation ("Accelr8"), the Agreement is amended, effective as of November 10, 2010, as set forth herein.
Amendment #1 to the Evaluation Corporation AgreementAccelr8 Technology Corp • April 18th, 2011 • Laboratory analytical instruments
Company FiledApril 18th, 2011 IndustryIncorporating the terms and conditions of the Evaluation Agreement, effective as of June 14, 2010 (hereinafter collectively referred to as the “Agreement"), made by and between Novartis Vaccines and Diagnostics, Inc. ("Novartis V&D") and Accelr8 Technology Corporation ("Accelr8”), the Agreement is amended, effective as of November 10, 2010 as set forth herein.